Surgical treatment of proximal humeral fractures with the transosseous suture fixation.


Journal

Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112

Informations de publication

Date de publication:
23 Jun 2021
Historique:
received: 13 04 2021
accepted: 11 06 2021
entrez: 24 6 2021
pubmed: 25 6 2021
medline: 28 10 2021
Statut: epublish

Résumé

The surgical treatment of displaced proximal humeral fractures is commonly affected by implant-related complications. We evaluated the functional and radiographic results of transosseous suture fixation in a series of displaced proximal humeral fractures (PHF). Sixty-four patients were retrospectively classified by age, sex, and the Neer fracture classification. Two-part greater tuberosity (2pGT) displaced fractures and 3-part (varus and valgus) and 4-part valgus impacted fractures were managed with fragment reduction and transosseous suture fixation. Patients with minimum follow-up of 24 months and assessed with the Constant-Murley score (CMS) were included. Radiological and medical complications, as well as reinterventions were also recorded. Forty-six patients with a mean follow-up of 58 (24-132) and a mean age of 58 years old were analyzed. Patients with 2pGT (n = 10) fractures had a CMS of 76 points (59-89); patients with 3-part fractures (n = 22) had a score of 67 points (13-91); and those with 4-part fractures (n = 14) had a score of 64 (24-76) points. The overall complication rate was 6 out of 46, and 4 patients required reintervention for different reasons. Patients presenting with 3-part varus fractures had significantly lower functional outcomes scores (p = 0.007). Humeral head osteonecrosis was present in 9 patients and significantly affected the functional outcomes (p < 0.05). However, only three out of nine patients with osteonecrosis required subsequent surgery at the indicated follow-up. The fracture reduction and transosseous fixation technique represents a safe technique with low complication and reintervention rates. The presence of humeral head necrosis did not lead to subsequent surgical intervention because no hardware had protruded. Level IV, retrospective study.

Sections du résumé

BACKGROUND BACKGROUND
The surgical treatment of displaced proximal humeral fractures is commonly affected by implant-related complications. We evaluated the functional and radiographic results of transosseous suture fixation in a series of displaced proximal humeral fractures (PHF).
METHODS METHODS
Sixty-four patients were retrospectively classified by age, sex, and the Neer fracture classification. Two-part greater tuberosity (2pGT) displaced fractures and 3-part (varus and valgus) and 4-part valgus impacted fractures were managed with fragment reduction and transosseous suture fixation. Patients with minimum follow-up of 24 months and assessed with the Constant-Murley score (CMS) were included. Radiological and medical complications, as well as reinterventions were also recorded.
RESULTS RESULTS
Forty-six patients with a mean follow-up of 58 (24-132) and a mean age of 58 years old were analyzed. Patients with 2pGT (n = 10) fractures had a CMS of 76 points (59-89); patients with 3-part fractures (n = 22) had a score of 67 points (13-91); and those with 4-part fractures (n = 14) had a score of 64 (24-76) points. The overall complication rate was 6 out of 46, and 4 patients required reintervention for different reasons. Patients presenting with 3-part varus fractures had significantly lower functional outcomes scores (p = 0.007). Humeral head osteonecrosis was present in 9 patients and significantly affected the functional outcomes (p < 0.05). However, only three out of nine patients with osteonecrosis required subsequent surgery at the indicated follow-up.
CONCLUSIONS CONCLUSIONS
The fracture reduction and transosseous fixation technique represents a safe technique with low complication and reintervention rates. The presence of humeral head necrosis did not lead to subsequent surgical intervention because no hardware had protruded.
LEVEL OF EVIDENCE METHODS
Level IV, retrospective study.

Identifiants

pubmed: 34162416
doi: 10.1186/s13018-021-02555-7
pii: 10.1186/s13018-021-02555-7
pmc: PMC8220733
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

405

Références

Acta Orthop Traumatol Turc. 2010;44(1):1-6
pubmed: 20513984
J Bone Joint Surg Br. 1976 Aug;58(3):313-7
pubmed: 956247
Injury. 2012 Feb;43(2):153-8
pubmed: 21570073
J Bone Joint Surg Am. 1970 Sep;52(6):1077-89
pubmed: 5455339
J Bone Joint Surg Am. 2007 Aug;89(8):1700-9
pubmed: 17671007
J Orthop Surg Res. 2010 Aug 23;5:60
pubmed: 20731844
J Bone Joint Surg Am. 2009 Mar 1;91 Suppl 2 Pt 1:8-21
pubmed: 19255196
Injury. 2014 Jan;45 Suppl 1:S29-37
pubmed: 24252574
J Bone Joint Surg Br. 2007 Sep;89(9):1206-9
pubmed: 17905959
J Bone Joint Surg Br. 2004 Aug;86(6):848-55
pubmed: 15330026
J Shoulder Elbow Surg. 2009 Nov-Dec;18(6):837-44
pubmed: 19748802
J Shoulder Elbow Surg. 2014 Mar;23(3):369-76
pubmed: 24291047
Injury. 2016 Dec;47 Suppl 7:S10-S13
pubmed: 28040070
J Bone Joint Surg Br. 1997 Mar;79(2):295-300
pubmed: 9119860
JAMA. 2015 Mar 10;313(10):1037-47
pubmed: 25756440
J Shoulder Elbow Surg. 1995 Mar-Apr;4(2):73-80
pubmed: 7600168
Clin Orthop Relat Res. 2006 Jan;442:115-20
pubmed: 16394749
J Shoulder Elbow Surg. 2004 Mar-Apr;13(2):191-5
pubmed: 14997098
J Orthop Surg (Hong Kong). 2014 Aug;22(2):195-8
pubmed: 25163954
J Shoulder Elbow Surg. 2011 Jul;20(5):747-55
pubmed: 21435907
Arch Orthop Trauma Surg. 2017 Dec;137(12):1685-1692
pubmed: 28929389
Injury. 2003 Jun;34(6):443-7
pubmed: 12767791
Int Orthop. 2002;26(1):13-6
pubmed: 11954840
J Orthop. 2019 Jun 05;17:106-109
pubmed: 31879485
J Bone Joint Surg Br. 1991 Mar;73(2):295-8
pubmed: 2005159

Auteurs

J Miquel (J)

Corporació Sanitària Parc Taulí, Parc Taulí, 1., 08208, Barcelona, Spain. joanmiquelnoguera@hotmail.com.

R Martínez (R)

Consorci Sanitari de l'Anoia, Avda Catalunya, 11, 08700, Igualada, Spain.

F Santana (F)

Parc de Salut Mar, Passeig Marítim, 25-29, 08003, Barcelona, Spain.

P Marimon (P)

Consorci Sanitari de l'Anoia, Avda Catalunya, 11, 08700, Igualada, Spain.

C Torrens (C)

Parc de Salut Mar, Passeig Marítim, 25-29, 08003, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH